Rankings
▼
Calendar
HRTX Q1 2023 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
HRTX
Heron Therapeutics, Inc.
$162M
Q1 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$30M
+26.3% YoY
Gross Profit
$13M
43.1% margin
Operating Income
-$33M
-111.6% margin
Net Income
-$33M
-110.6% margin
EPS (Diluted)
$-0.27
QoQ Revenue Growth
-1.4%
Cash Flow
Operating Cash Flow
-$25M
Free Cash Flow
-$25M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$221M
Total Liabilities
$232M
Stockholders' Equity
-$11M
Cash & Equivalents
$27M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$30M
$23M
+26.3%
Gross Profit
$13M
$12M
+5.4%
Operating Income
-$33M
-$63M
+47.5%
Net Income
-$33M
-$64M
+48.7%
Revenue Segments
C I N V A N T I
$23M
78%
Z Y N R E L E F
$4M
12%
S U S T O L
$3M
10%
← FY 2023
All Quarters
Q2 2023 →